NEUTRALISING ANTIBODIES TO INTERFERON-BETA PREDICT CONVERSION TO SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS IN PATIENTS WITH MULTIPLE SCLEROSIS

被引：0
|
作者：
Gafson, Arie
Worthington, Viki
Lakdawala, Neghat
Giovannoni, Gavin
Farrell, Rachel
机构：
[1] UCL, Inst Neurol, London WC1E 6BT, England
[2] Barts & London Queen Marys Sch Med & Dent, London, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2013年 / 84卷 / 11期
关键词：
D O I：
10.1136/jnnp-2013-306573.176
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Persistent neutralising antibodies to interferon-beta and clinical outcomes in multiple sclerosis patients
    Costelloe, L.
    O'Rourke, K.
    Tubridy, N.
    Hutchinson, M.
    MULTIPLE SCLEROSIS, 2006, 12 : S205 - S205
  • [2] Interferon-beta neutralising antibodies in Canadian multiple sclerosis patients treated with different interferon-beta products
    Grossberg, S. E.
    Gehshan, A.
    Long, C.
    Chuppa, S. L.
    Nicholson, K.
    Grossberg, L. D.
    MULTIPLE SCLEROSIS, 2006, 12 : S207 - S208
  • [3] Neutralising antibodies to interferon-beta therapy in relapsing multiple sclerosis: a pilot study
    Lau, A. Y. L.
    Chan, E.
    Lau, K. K.
    Mok, V
    Siu, D. Y. W.
    Lee, R.
    HONG KONG MEDICAL JOURNAL, 2019, 25 (04) : 22 - 25
  • [4] In vivo bioactivity of interferon-beta in multiple sclerosis patients with neutralising antibodies is titre-dependent
    Sominanda, A.
    Hillert, J.
    Fogdell-Hahn, A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (01): : 57 - 62
  • [5] Frequency and clinical aspect of neutralising antibodies to interferon-beta in a large cohort of multiple sclerosis patients
    Bucello, S.
    Liberatore, G.
    Moiola, L.
    Radaelli, M.
    Sala, A.
    Capobianco, M.
    Bertolotto, A.
    Martinelli, V.
    Comi, G.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S130 - S130
  • [6] Neutralising antibodies against interferon beta in multiple sclerosis
    Mikol, D
    LANCET, 2004, 363 (9403): : 167 - 168
  • [7] Neutralising Antibodies to Interferon-beta Therapy in Chinese Patients with Relapsing and Remitting Multiple Sclerosis.
    Ip, W. K.
    Lau, A. Y. L.
    Zhang, S.
    Au, C. C. K.
    Wong, W.
    Lau, K. K.
    Li, P.
    Chan, E. Y. T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 416 - 417
  • [8] Antibodies against interferon-beta in multiple sclerosis
    Aarskog, Nina Karin
    Maroy, Tove
    Myhr, Kjell-Morten
    Vedeler, Christian A.
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 212 (1-2) : 148 - 150
  • [9] Differential patterns of interferon-beta usage in secondary progressive multiple sclerosis
    Sellner, J.
    Gebhardt, A.
    Buehler, R.
    Findling, O.
    Humpert, S.
    Blatter-Arifi, V.
    Lienert, C.
    Mattle, H.-P.
    JOURNAL OF NEUROLOGY, 2007, 254 : 71 - 71
  • [10] Correlation between anti-interferon-beta binding and neutralising antibodies in multiple sclerosis patients on interferon-beta therapy
    Jensen, P. E. H.
    Sellebjerg, F.
    Sondergaard, H. B.
    Sorensen, P. S.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S120 - S120
12345